共 53 条
- [1] Forner A., Reig M., Bruix J., Hepatocellular carcinoma, Lancet (London England), 391, pp. 1301-1314, (2018)
- [2] Siegel R.L., Giaquinto A.N., Jemal A., Cancer statistics, 2024, CA Cancer J Clin, 74, pp. 12-49, (2024)
- [3] Bray F., Laversanne M., Sung H., Ferlay J., Siegel R.L., Soerjomataram I., Et al., Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 74, pp. 229-263, (2024)
- [4] Addissouky T.A., Sayed I.E.T.E., Ali M.M.A., Wang Y., Baz A.E., Khalil A.A., Et al., Latest advances in hepatocellular carcinoma management and prevention through advanced technologies, Egypt Liv J, 14, (2024)
- [5] Peng Y., Wu X., Zhang Y., Yin Y., Chen X., Zheng D., Et al., An overview of traditional Chinese medicine in the treatment after radical resection of hepatocellular carcinoma, J Hepatocell Carcinoma, 10, pp. 2305-2321, (2023)
- [6] Jia W., Wang L., Using traditional Chinese medicine to treat hepatocellular carcinoma by targeting tumor immunity, Evid Based Complement Altern Med eCAM, 2020, (2020)
- [7] Li J.J., Liang Q., Sun G.C., Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: a focus on epithelial-mesenchymal transition, J Integr Med, 19, pp. 469-477, (2021)
- [8] Shao G., Liu Y., Lu L., Wang L., Ji G., Xu H., Therapeutic potential of traditional Chinese medicine in the prevention and treatment of digestive inflammatory cancer transformation: Portulaca oleracea L. as a promising drug, J Ethnopharmacol, 327, (2024)
- [9] Qian Y., Coordinated regulation of the body and function, Jiangsu J Tradit Chin Med, 39, (2007)
- [10] Yuan H., Niu Q., Shang X., Zhang L., Li L., Yang H., Et al., Impact of traditional Chinese medicine on prognosis of patients with hepatocellular carcinoma: a retrospective cohort study, Integr Cancer Ther, 22, (2023)